Human placenta: in situ hybridization for cytomegalovirus mRNA using CMV Probe, Anti-Fluorescein Antibody and BOND Polymer Refine Detection.

BOND CMV Probe

bond-cmv-probe
BOND ISH probes are provided in a ready-to-use format and their use has been validated together with Leica ancillaries and BOND Polymer Refine detection for quality you can depend on. Turnaround time is rapid – around 4 hours 20 minutes using the standard BOND protocol, enabling the rapid turnaround of results vs. typical overnight protocols or outsourced testing, for improved patient care.

Background
Cytomegalovirus CMV is a member of the Beta Herpes Virus family, transmitted via body fluids, and can establish primary infection, latent infection and subsequent viral reactivation.

CMV is a common opportunistic pathogen, capable of causing serious disease in immunocompromised individuals such as AIDS patients, transplant patients and in neonates.

Congenital CMV is a result of intrauterine infection and although the majority of children are asymptomatic, congenital CMV can result in sensorineural hearing loss, cognitive, motor and visual deficits and seizures.
  • This item replaces CMV
    PB0614
    5.5 ml Bond CMV Probe

Product Specifications

Product Specifications

PB0614
In Vitro Diagnostic Use
5.5 mL
Tissue
RNA ISH
Viral
Chromogenic
Ready-to-Use
For BOND

Documents

Documents

PB0614

Resources

Resources

BOND ISH probes are provided in a ready-to-use format and their use has been validated together with Leica ancillaries and BOND Polymer Refine detection for quality you can depend on. Turnaround time is rapid – around 4 hours 20 minutes using the standard BOND protocol, enabling the rapid turnaround of results vs. typical overnight protocols or outsourced testing, for improved patient care.

Background
Cytomegalovirus CMV is a member of the Beta Herpes Virus family, transmitted via body fluids, and can establish primary infection, latent infection and subsequent viral reactivation.

CMV is a common opportunistic pathogen, capable of causing serious disease in immunocompromised individuals such as AIDS patients, transplant patients and in neonates.

Congenital CMV is a result of intrauterine infection and although the majority of children are asymptomatic, congenital CMV can result in sensorineural hearing loss, cognitive, motor and visual deficits and seizures.

Recently Viewed

View All